Annual report pursuant to Section 13 and 15(d)

Income Tax - Schedule of Net Deferred Tax Asset (Details)

v3.10.0.1
Income Tax - Schedule of Net Deferred Tax Asset (Details) - USD ($)
Apr. 30, 2018
Apr. 30, 2017
Income Tax Disclosure [Abstract]    
Net operating loss carryover $ 1,905,000 $ 1,159,000
Stock-based compensation 1,580,000
Alternative minimum tax credit carryover 438,000
Capitalized R & D costs 163,145
Subtotal 4,086,145 1,159,000
Less: valuation allowance (3,648,000) (1,159,000)
Net deferred tax asset $ 438,145